Methods and mechanisms for the development of MTX resistance in human lymphoid cells

Conditions are described for the development of methotrexate resistance in CCRF/CEM human lymphoid cells and an attempt is made to distinguish between those conditions that lead to methotrexate resistance through impairment of cellular transport of methotrexate and those that lead to resistance thro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of cancer 1983-01, Vol.31 (1), p.45-50
Hauptverfasser: Alam, A., Geddes, A. J., North, A. C. T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 50
container_issue 1
container_start_page 45
container_title International journal of cancer
container_volume 31
creator Alam, A.
Geddes, A. J.
North, A. C. T.
description Conditions are described for the development of methotrexate resistance in CCRF/CEM human lymphoid cells and an attempt is made to distinguish between those conditions that lead to methotrexate resistance through impairment of cellular transport of methotrexate and those that lead to resistance through enhanced production of dihydrofolate reductase. A restistant line showing a 200‐fold enhancement of dihydrofolate reductase has been obtained. The CCRF/CEM human cells are much more sensitive to methotrexate than are murine cells.
doi_str_mv 10.1002/ijc.2910310108
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80420779</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>13779295</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3718-59f938e5275c434c569571b71eee0f85c0cf2877f3f815a64a3ac7046aa9ff5a3</originalsourceid><addsrcrecordid>eNqFkD1PwzAQQC0EKqWwsiF5Yks5x3Fsj6jio6gVS5HYItc5K67yUeIE1H9PqlbAxnTDvXs6PUKuGUwZQHznN3YaawacAQN1QsYMtIwgZuKUjAcAIsl4ek4uQtgAMCYgGZFRqnisEjUmqyV2RZMHauqcVmgLU_tQBeqalnYF0hw_sWy2FdYdbRxdrt5pi8GHztQWqa9p0VempuWu2haNz6nFsgyX5MyZMuDVcU7I2-PDavYcLV6f5rP7RWS5ZCoS2mmuUMRS2IQnVqRaSLaWDBHBKWHBulhJ6bhTTJg0MdxYCUlqjHZOGD4htwfvtm0-egxdVvmw_8DU2PQhU5DEIKX-F2R8oGItBnB6AG3bhNCiy7atr0y7yxhk-97Z0Dv77T0c3BzN_brC_Ac_Bh72-rD_8iXu_rFl85fZH_c3SAyLXg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>13779295</pqid></control><display><type>article</type><title>Methods and mechanisms for the development of MTX resistance in human lymphoid cells</title><source>Wiley-Blackwell Journals</source><source>MEDLINE</source><creator>Alam, A. ; Geddes, A. J. ; North, A. C. T.</creator><creatorcontrib>Alam, A. ; Geddes, A. J. ; North, A. C. T.</creatorcontrib><description>Conditions are described for the development of methotrexate resistance in CCRF/CEM human lymphoid cells and an attempt is made to distinguish between those conditions that lead to methotrexate resistance through impairment of cellular transport of methotrexate and those that lead to resistance through enhanced production of dihydrofolate reductase. A restistant line showing a 200‐fold enhancement of dihydrofolate reductase has been obtained. The CCRF/CEM human cells are much more sensitive to methotrexate than are murine cells.</description><identifier>ISSN: 0020-7136</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/ijc.2910310108</identifier><identifier>PMID: 6832848</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Biological Transport ; Cell Line ; Drug Resistance ; Female ; Folic Acid Antagonists ; Humans ; In Vitro Techniques ; Lymphocytes - drug effects ; Methotrexate - pharmacology ; Tetrahydrofolate Dehydrogenase - metabolism</subject><ispartof>International journal of cancer, 1983-01, Vol.31 (1), p.45-50</ispartof><rights>Copyright © 1983 Wiley‐Liss, Inc., A Wiley Company</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3718-59f938e5275c434c569571b71eee0f85c0cf2877f3f815a64a3ac7046aa9ff5a3</citedby><cites>FETCH-LOGICAL-c3718-59f938e5275c434c569571b71eee0f85c0cf2877f3f815a64a3ac7046aa9ff5a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fijc.2910310108$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fijc.2910310108$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27915,27916,45565,45566</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6832848$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alam, A.</creatorcontrib><creatorcontrib>Geddes, A. J.</creatorcontrib><creatorcontrib>North, A. C. T.</creatorcontrib><title>Methods and mechanisms for the development of MTX resistance in human lymphoid cells</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>Conditions are described for the development of methotrexate resistance in CCRF/CEM human lymphoid cells and an attempt is made to distinguish between those conditions that lead to methotrexate resistance through impairment of cellular transport of methotrexate and those that lead to resistance through enhanced production of dihydrofolate reductase. A restistant line showing a 200‐fold enhancement of dihydrofolate reductase has been obtained. The CCRF/CEM human cells are much more sensitive to methotrexate than are murine cells.</description><subject>Biological Transport</subject><subject>Cell Line</subject><subject>Drug Resistance</subject><subject>Female</subject><subject>Folic Acid Antagonists</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Lymphocytes - drug effects</subject><subject>Methotrexate - pharmacology</subject><subject>Tetrahydrofolate Dehydrogenase - metabolism</subject><issn>0020-7136</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkD1PwzAQQC0EKqWwsiF5Yks5x3Fsj6jio6gVS5HYItc5K67yUeIE1H9PqlbAxnTDvXs6PUKuGUwZQHznN3YaawacAQN1QsYMtIwgZuKUjAcAIsl4ek4uQtgAMCYgGZFRqnisEjUmqyV2RZMHauqcVmgLU_tQBeqalnYF0hw_sWy2FdYdbRxdrt5pi8GHztQWqa9p0VempuWu2haNz6nFsgyX5MyZMuDVcU7I2-PDavYcLV6f5rP7RWS5ZCoS2mmuUMRS2IQnVqRaSLaWDBHBKWHBulhJ6bhTTJg0MdxYCUlqjHZOGD4htwfvtm0-egxdVvmw_8DU2PQhU5DEIKX-F2R8oGItBnB6AG3bhNCiy7atr0y7yxhk-97Z0Dv77T0c3BzN_brC_Ac_Bh72-rD_8iXu_rFl85fZH_c3SAyLXg</recordid><startdate>19830115</startdate><enddate>19830115</enddate><creator>Alam, A.</creator><creator>Geddes, A. J.</creator><creator>North, A. C. T.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>19830115</creationdate><title>Methods and mechanisms for the development of MTX resistance in human lymphoid cells</title><author>Alam, A. ; Geddes, A. J. ; North, A. C. T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3718-59f938e5275c434c569571b71eee0f85c0cf2877f3f815a64a3ac7046aa9ff5a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><topic>Biological Transport</topic><topic>Cell Line</topic><topic>Drug Resistance</topic><topic>Female</topic><topic>Folic Acid Antagonists</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Lymphocytes - drug effects</topic><topic>Methotrexate - pharmacology</topic><topic>Tetrahydrofolate Dehydrogenase - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alam, A.</creatorcontrib><creatorcontrib>Geddes, A. J.</creatorcontrib><creatorcontrib>North, A. C. T.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alam, A.</au><au>Geddes, A. J.</au><au>North, A. C. T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Methods and mechanisms for the development of MTX resistance in human lymphoid cells</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>1983-01-15</date><risdate>1983</risdate><volume>31</volume><issue>1</issue><spage>45</spage><epage>50</epage><pages>45-50</pages><issn>0020-7136</issn><eissn>1097-0215</eissn><abstract>Conditions are described for the development of methotrexate resistance in CCRF/CEM human lymphoid cells and an attempt is made to distinguish between those conditions that lead to methotrexate resistance through impairment of cellular transport of methotrexate and those that lead to resistance through enhanced production of dihydrofolate reductase. A restistant line showing a 200‐fold enhancement of dihydrofolate reductase has been obtained. The CCRF/CEM human cells are much more sensitive to methotrexate than are murine cells.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>6832848</pmid><doi>10.1002/ijc.2910310108</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0020-7136
ispartof International journal of cancer, 1983-01, Vol.31 (1), p.45-50
issn 0020-7136
1097-0215
language eng
recordid cdi_proquest_miscellaneous_80420779
source Wiley-Blackwell Journals; MEDLINE
subjects Biological Transport
Cell Line
Drug Resistance
Female
Folic Acid Antagonists
Humans
In Vitro Techniques
Lymphocytes - drug effects
Methotrexate - pharmacology
Tetrahydrofolate Dehydrogenase - metabolism
title Methods and mechanisms for the development of MTX resistance in human lymphoid cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T18%3A50%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Methods%20and%20mechanisms%20for%20the%20development%20of%20MTX%20resistance%20in%20human%20lymphoid%20cells&rft.jtitle=International%20journal%20of%20cancer&rft.au=Alam,%20A.&rft.date=1983-01-15&rft.volume=31&rft.issue=1&rft.spage=45&rft.epage=50&rft.pages=45-50&rft.issn=0020-7136&rft.eissn=1097-0215&rft_id=info:doi/10.1002/ijc.2910310108&rft_dat=%3Cproquest_cross%3E13779295%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=13779295&rft_id=info:pmid/6832848&rfr_iscdi=true